| Title: | An interactive atlas of genomic, proteomic, and metabolomic biomarkers promotes the potential of proteins to predict complex diseases |
| Journal: | Scientific Reports |
| Published: | 3 Jun 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38830935/ |
| DOI: | https://doi.org/10.1038/s41598-024-63399-9 |
Publication 11926
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Multiomics analyses have identified multiple potential biomarkers of the incidence and prevalence of complex diseases. However, it is not known which type of biomarker is optimal for clinical purposes. Here, we make a systematic comparison of 90 million genetic variants, 1453 proteins, and 325 metabolites from 500,000 individuals with complex diseases from the UK Biobank. A machine learning pipeline consisting of data cleaning, data imputation, feature selection, and model training using cross-validation and comparison of the results on holdout test sets showed that proteins were most predictive, followed by metabolites, and genetic variants. Only five proteins per disease resulted in median (min-max) areas under the receiver operating characteristic curves for incidence of 0.79 (0.65-0.86) and 0.84 (0.70-0.91) for prevalence. In summary, our work suggests the potential of predicting complex diseases based on a limited number of proteins. We provide an interactive atlas (macd.shinyapps.io/ShinyApp/) to find genomic, proteomic, or metabolomic biomarkers for different complex diseases.</p>
8 Authors
- Martin Smelik
- Yelin Zhao
- Xinxiu Li
- Joseph Loscalzo
- Oleg Sysoev
- Firoj Mahmud
- Dina Mansour Aly
- Mikael Benson
1 Application
| Application ID | Title |
|---|---|
| 102162 | Digital Twins to find biomarkers for early diagnosis of cancer |
Enabling scientific discoveries that improve human health